trending Market Intelligence /marketintelligence/en/news-insights/trending/p5lx-3ftrnrq7x5lhu2zww2 content esgSubNav
In This List

Respiri appoints 2 directors

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Respiri appoints 2 directors

Respiri Ltd. appointed Mark Ziirsen and Brendan Mason to its board, replacing Leon L'Huillier and John Ribot-de-Bresac who are retiring.

Ziirsen is a nonexecutive director at SmartTrans Holdings Ltd. He served as Admedus Ltd.'s CFO as well as Cochlear Ltd.'s director of finance and IT for Asia Pacific in the past.

Mason is the CEO and managing director of SmartTrans. He served as Cochlear's general manager from 2007 to 2014.

Australia-based Respiri develops medical devices and mobile health applications.